Increased nitric oxide in exhaled air of asthmatic patients

Lancet. 1994 Jan 15;343(8890):133-5. doi: 10.1016/s0140-6736(94)90931-8.


Nitric oxide (NO) gas is produced by various cells within the lower respiratory tract, including inflammatory and epithelial cells, and is detectable in the exhaled air of normal human subjects. We have measured exhaled NO in patients with asthma, since several cell types that are activated in asthma can produce NO after induction. NO was measured reproducibly by a slow vital capacity manoeuvre and an adapted chemiluminescence analyser. NO was detectable in exhaled air of 67 control subjects (mean peak concentration 80.2 [SE 4.1] ppb) and was significantly reduced by inhalation of the specific NO synthase inhibitor NG-monomethyl-L-arginine. 61 non-steroid-treated asthmatic subjects had significantly higher peak expired NO concentrations than controls (283 [16] ppb, p < 0.001) but 52 asthmatic patients receiving inhaled corticosteroids had levels similar to controls (101 [7] ppb). High exhaled NO concentrations in asthmatic patients may reflect induction of NO synthase, which is known to be inhibited by steroids. Measurement of exhaled NO concentrations may be clinically useful in detection and management of cytokine-mediated inflammatory lung disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Asthma / metabolism*
  • Asthma / physiopathology
  • Breath Tests
  • Female
  • Humans
  • Luminescent Measurements
  • Male
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism*
  • Reproducibility of Results
  • Respiration / physiology
  • Spirometry
  • omega-N-Methylarginine


  • Adrenal Cortex Hormones
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine